PD-1 abrogates the prolonged persistence of CD8+ CAR-T cells with 4-1BB co-stimulation

被引：0

作者：

Feng Li

Zhen Zhang

Yujing Xuan

Daiqun Zhang

Jinyan Liu

Aitian Li

Shumin Wang

Ting Li

Xiaojuan Shi

Yi Zhang

机构：

[1] The First Affiliated Hospital of Zhengzhou University,Biotherapy Center

[2] The First Affiliated Hospital of Zhengzhou University,Cancer Center

[3] State Key Laboratory of Esophageal Cancer Prevention & Treatment,School of Life Sciences

[4] Henan Key Laboratory for Tumor Immunology and Biotherapy,undefined

[5] Zhengzhou University,undefined

来源：

Signal Transduction and Targeted Therapy | / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Generation of suppressor CD8+T cells by triggering 4-1BB
Choi, Beorn K.
Kang, Woo J.
Kim, Young H.
Kwon, Byoung S.
JOURNAL OF IMMUNOLOGY, 2006, 176 : S186 - S186
[22] Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Guedan, Sonia
Posey, Avery D., Jr.
Shaw, Carolyn
Wing, Anna
Da, Tong
Patel, Prachi R.
McGettigan, Shannon E.
Casado-Medrano, Victoria
Kawalekar, Omkar U.
Uribe-Herranz, Mireia
Song, Decheng
Melenhorst, J. Joseph
Lacey, Simon F.
Scholler, John
Keith, Brian
Young, Regina M.
June, Carl H.
JCI INSIGHT, 2018, 3 (01):
[23] Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
McNamara, James O., II
Kolonias, Despina
Pastor, Fernando
Mittler, Robert S.
Chen, Lieping
Giangrande, Paloma H.
Sullenger, Bruce
Gilboa, Eli
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01): : 376 - 386
[24] 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells
Kim, YH
Seo, SK
Choi, BK
Kang, WJ
Kim, CH
Lee, SK
Kwon, YS
CELLULAR IMMUNOLOGY, 2005, 238 (02) : 76 - 86
[25] 4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells
Roselli, Emiliano
Boucher, Justin C.
Li, Gongbo
Kotani, Hiroshi
Spitler, Kristen
Reid, Kayla
Cervantes, Estelle, V
Bulliard, Yannick
Tu, Nhan
Lee, Sae Bom
Yu, Bin
Locke, Frederick L.
Davila, Marco L.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
[26] Engineering of a trispecific tumor-targeted immunotherapy incorporating 4-1BB co-stimulation and PD-L1 blockade
Warmuth, Stefan
Gunde, Tea
Snell, Daniel
Brock, Matthias
Weinert, Christopher
Simonin, Alexandre
Hess, Christian
Tietz, Julia
Johansson, Maria
Spiga, Fabio Mario
Heiz, Robin
Fluckiger, Naomi
Wagen, Sandro
Zeberer, Julia
Diem, Dania
Mahler, Dana
Wickihalder, Belinda
Muntwiler, Simone
Chatterjee, Bithi
Kuttner, Benjamin
Bommer, Bettina
Yaman, Yasemin
Lichtlen, Peter
Urech, David
ONCOIMMUNOLOGY, 2021, 10 (01):
[27] Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
Chen, Shihao
Lee, Li-Fen
Fisher, Timothy S.
Jessen, Bart
Elliott, Mark
Evering, Winston
Logronio, Kathryn
Tu, Guang Huan
Tsaparikos, Konstantinos
Li, Xiaoai
Wang, Hui
Ying, Chi
Xiong, Mengli
VanArsdale, Todd
Lin, John C.
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 149 - 160
[28] Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells
Wei, Cheng
Xia, Kangfu
Xie, Yucheng
Ye, Sishi
Ding, Yanghui
Liu, Zairu
Zheng, Rong
Long, Jing
Wei, Qinchuan
Li, Yumei
Yang, Dongxia
Xu, Xiaojun
Zhao, Ai
Gao, Jimin
FRONTIERS IN ONCOLOGY, 2022, 12
[29] Expression of Programmed Death-1 (PD-1) on CD4+ and CD8+ T cells in Rheumatoid Arthritis
Shufeng Li
Wensheng Liao
Meng Chen
Shiying Shan
Yuanlin Song
Shuzhen Zhang
Haihan Song
Zhen Yuan
Inflammation, 2014, 37 : 116 - 121
[30] TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells
Zahm, Christopher D.
Colluru, Viswa T.
McIlwain, Sean J.
Ong, Irene M.
McNeel, Douglas G.
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (11) : 1364 - 1374

← 1 2 3 4 5 →